(5S) -3-[(S)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as CETP inhibitors

Details for Australian Patent Application No. 2005324127 (hide)

Owner Bayer HealthCare AG

Inventors Weber, Olaf; Bischoff, Hilmar; Wuttke, Martina; Vakalopoulos, Alexandros; Gielen-Haertwig Heike; Thutewohl, Michael; Schmeck, Carsten; Li, Volkhart

Agent Davies Collison Cave

Pub. Number AU-A-2005324127

PCT Pub. Number WO2006/072362

Priority 102004061003.7 18.12.04 DE; 102004060998.5 18.12.04 DE; 102004060999.3 18.12.04 DE; 102004061001.0 18.12.04 DE; 102004061002.9 18.12.04 DE

Filing date 10 December 2005

Wipo publication date 13 July 2006

International Classifications

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/072362 Priority application(s): WO2006/072362

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005324132-Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release

2005324120-Gear pair consisting of a crown gear and of a pinion gear